Greg Gojanovich to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications Greg Gojanovich has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.393
-
Martin AJ, Clark M, Gojanovich G, Manzoor F, Miller K, Kline DE, Morillon YM, Wang B, Tisch R. Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues. JCI Insight. 2016 Oct 20; 1(17):e87636.
Score: 0.136
-
Gojanovich GS, Hess PR. Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes. Clin Dev Immunol. 2012; 2012:380289.
Score: 0.100
-
Ross P, Buntzman AS, Vincent BG, Grover EN, Gojanovich GS, Collins EJ, Frelinger JA, Hess PR. Allelic diversity at the DLA-88 locus in Golden Retriever and Boxer breeds is limited. Tissue Antigens. 2012 Aug; 80(2):175-83.
Score: 0.100
-
Maurice Morillon Y, Martin A, Gojanovich G, Wang B, Tisch R. Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes. Arch Immunol Ther Exp (Warsz). 2015 Aug; 63(4):239-50.
Score: 0.030
-
Ross P, Holmes JC, Gojanovich GS, Hess PR. A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88. Vet Immunol Immunopathol. 2012 Dec 15; 150(3-4):206-12.
Score: 0.026